Literature DB >> 1710206

Oncofetal expression of the human intestinal mucin glycoprotein antigens in gastrointestinal epithelium defined by monoclonal antibodies.

P J Hertzog1, H C Robinson, J Ma, I R Mackay, A W Linnane.   

Abstract

A mucin preparation from a colonic adenocarcinoma was used to prepare monoclonal antibodies (MAbs) that reacted specifically either with normal adult small-intestine mucin antigen(s) (SIMA), or normal adult large-intestine mucin antigen(s) (LIMA). Both SIMA and LIMA show a unique oncofetal pattern of expression. Thus SIMA was expressed in early fetal stomach, large and small intestines but thereafter only in the normal small intestine. SIMA expression was detected immunohistochemically in cancers of the colorectum (82/112) and stomach (48/86). LIMA was detected in the stomach of the early fetus but thereafter only in the normal large intestine. LIMA expression was detected in 61/86 cancers of the stomach. Moreover, both SIMA and LIMA were expressed inappropriately in mucosa adjacent to tumors, indicative of the detection of possible pre-malignant epithelium. We used a sandwich ELISA and biochemical procedures to show that the SIMA and LIMA molecules were large extensively glycosylated multi-unit mucin glycoproteins that differed markedly from each other. SIMA, whether extracted from normal small-intestine or colonic cancers, had a molecular weight above 1.000 kDa, a mean buoyant density 1.33 g/ml and s value of 4.8. LIMA had a molecular weight above 10.000 kDa, a mean buoyant density 1.45 g/ml and an s value 9.5. The SIMA and LIMA epitopes were judged to be carbohydrate in nature by reason of their resistance to harsh physical chemical treatments or protease digestion, and sensitivity to periodate oxidation, neuraminidase or beta elimination. Only the SIMA epitope was sensitive to neuraminidase. In conclusion, MAbs to carbohydrate-dependent epitopes on SIMA and LIMA identify the oncofetal pattern of expression of these distinct intestinal mucin glycoproteins in colonic and gastric carcinoma. These MAbs will be useful in further studies of the significance of oncofetal mucin expression during carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1710206     DOI: 10.1002/ijc.2910480308

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

1.  Expression of MUC2 gene in gastric regenerative, metaplastic, and neoplastic epithelia.

Authors:  M Mitsuuchi; Y Hinoda; F Itoh; T Endo; M Satoh; P X Xing; K Imai
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

2.  Relationship between biological behavior and phenotypic expression in undifferentiated-type gastric carcinomas.

Authors:  Akira Kabashima; Takashi Yao; Yoshihiko Maehara; Masazumi Tsuneyoshi
Journal:  Gastric Cancer       Date:  2005       Impact factor: 7.370

3.  Mucin gene expression in human embryonic and fetal intestine.

Authors:  M P Buisine; L Devisme; T C Savidge; C Gespach; B Gosselin; N Porchet; J P Aubert
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

4.  Establishment of conditionally immortalized epithelial cell lines from both colon and small intestine of adult H-2Kb-tsA58 transgenic mice.

Authors:  R H Whitehead; P E VanEeden; M D Noble; P Ataliotis; P S Jat
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

5.  The adenoma-carcinoma sequence in the colorectum--early appearance of a hierarchy of small intestinal mucin antigen (SIMA) epitopes and correlation with malignant potential.

Authors:  S J Pilbrow; P J Hertzog; A W Linnane
Journal:  Br J Cancer       Date:  1992-10       Impact factor: 7.640

6.  Aberrant expression of intestinal mucin antigens associated with colorectal carcinoma defined by a panel of monoclonal antibodies.

Authors:  P J Hertzog; S J Pilbrow; J Pedersen; A L Polglase; M Lawson; A W Linnane
Journal:  Br J Cancer       Date:  1991-11       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.